Dechra acquisitions perform well

Pet drugs firm Dechra told shareholders at its AGM that its first quarter performance was in line with management expectations and all of its recent acquisitions are performing well.

The firm, which manufactures drugs in Skipton, announced that its generic antibiotic Amoxiclav had received approval from the US Food and Drug Administration. This registration is for two of four different dosage strengths of tablets.